Bright Minds Biosciences (DRUG) Competitors $24.81 -1.12 (-4.32%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$26.06 +1.25 (+5.02%) As of 07/11/2025 06:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock DRUG vs. CDMO, QURE, CRMD, CRON, GHRS, SNDX, IMNM, GYRE, VIR, and DNAShould you be buying Bright Minds Biosciences stock or one of its competitors? The main competitors of Bright Minds Biosciences include Avid Bioservices (CDMO), uniQure (QURE), CorMedix (CRMD), Cronos Group (CRON), GH Research (GHRS), Syndax Pharmaceuticals (SNDX), Immunome (IMNM), Gyre Therapeutics (GYRE), Vir Biotechnology (VIR), and Ginkgo Bioworks (DNA). These companies are all part of the "pharmaceutical products" industry. Bright Minds Biosciences vs. Its Competitors Avid Bioservices uniQure CorMedix Cronos Group GH Research Syndax Pharmaceuticals Immunome Gyre Therapeutics Vir Biotechnology Ginkgo Bioworks Avid Bioservices (NASDAQ:CDMO) and Bright Minds Biosciences (NASDAQ:DRUG) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, earnings, risk, media sentiment and valuation. Does the media favor CDMO or DRUG? In the previous week, Bright Minds Biosciences had 2 more articles in the media than Avid Bioservices. MarketBeat recorded 3 mentions for Bright Minds Biosciences and 1 mentions for Avid Bioservices. Avid Bioservices' average media sentiment score of 0.00 beat Bright Minds Biosciences' score of -0.02 indicating that Avid Bioservices is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avid Bioservices 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Bright Minds Biosciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk & volatility, CDMO or DRUG? Avid Bioservices has a beta of 1.39, indicating that its stock price is 39% more volatile than the S&P 500. Comparatively, Bright Minds Biosciences has a beta of -6.01, indicating that its stock price is 701% less volatile than the S&P 500. Do insiders and institutionals have more ownership in CDMO or DRUG? 97.2% of Avid Bioservices shares are held by institutional investors. Comparatively, 40.5% of Bright Minds Biosciences shares are held by institutional investors. 3.1% of Avid Bioservices shares are held by company insiders. Comparatively, 42.7% of Bright Minds Biosciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has better earnings & valuation, CDMO or DRUG? Bright Minds Biosciences has lower revenue, but higher earnings than Avid Bioservices. Bright Minds Biosciences is trading at a lower price-to-earnings ratio than Avid Bioservices, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAvid Bioservices$139.91M5.71-$140.75M-$2.39-5.23Bright Minds BiosciencesN/AN/A-$2.06M-$0.36-68.92 Is CDMO or DRUG more profitable? Bright Minds Biosciences has a net margin of 0.00% compared to Avid Bioservices' net margin of -101.07%. Bright Minds Biosciences' return on equity of -14.56% beat Avid Bioservices' return on equity.Company Net Margins Return on Equity Return on Assets Avid Bioservices-101.07% -33.18% -8.45% Bright Minds Biosciences N/A -14.56%-14.29% Do analysts prefer CDMO or DRUG? Avid Bioservices currently has a consensus price target of $12.25, suggesting a potential downside of 1.96%. Bright Minds Biosciences has a consensus price target of $83.25, suggesting a potential upside of 235.55%. Given Bright Minds Biosciences' stronger consensus rating and higher possible upside, analysts clearly believe Bright Minds Biosciences is more favorable than Avid Bioservices.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avid Bioservices 0 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Bright Minds Biosciences 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.13 SummaryBright Minds Biosciences beats Avid Bioservices on 10 of the 16 factors compared between the two stocks. Get Bright Minds Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for DRUG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DRUG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DRUG vs. The Competition Export to ExcelMetricBright Minds BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$174.76M$2.94B$5.55B$9.11BDividend YieldN/A2.42%5.07%4.01%P/E Ratio-68.9120.7128.2120.26Price / SalesN/A292.82432.0099.74Price / CashN/A42.1137.1257.67Price / Book26.977.638.045.49Net Income-$2.06M-$55.05M$3.19B$250.45M7 Day Performance-12.33%8.43%3.63%4.79%1 Month Performance-12.58%5.42%4.06%7.68%1 Year Performance2,477.66%2.03%30.02%16.44% Bright Minds Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DRUGBright Minds Biosciences2.0993 of 5 stars$24.81-4.3%$83.25+235.6%+2,386.0%$174.76MN/A-68.91N/ACDMOAvid Bioservices0.6154 of 5 stars$12.50+0.1%$12.25-2.0%+56.2%$799.18M$139.91M-5.23320News CoverageHigh Trading VolumeQUREuniQure2.7303 of 5 stars$14.31-0.8%$37.82+164.3%+61.6%$789.86M$27.12M-3.26500CRMDCorMedix2.7729 of 5 stars$11.42-1.7%$17.14+50.1%+128.5%$788.13M$82.55M51.9130Positive NewsCRONCronos Group1.5753 of 5 stars$2.04flatN/A-12.2%$786.79M$117.61M15.69450News CoverageGHRSGH Research1.9879 of 5 stars$15.01+0.7%$32.00+113.2%+33.4%$776MN/A-19.0010SNDXSyndax Pharmaceuticals3.1791 of 5 stars$8.73-3.0%$35.80+310.1%-59.2%$774.43M$23.68M-2.26110Analyst ForecastIMNMImmunome2.0964 of 5 stars$8.69-1.7%$23.33+168.5%-33.4%$769.19M$9.04M-2.7340Positive NewsGYREGyre Therapeutics0.2336 of 5 stars$7.62-6.3%N/A-40.6%$762.25M$105.76M381.1940VIRVir Biotechnology3.6117 of 5 stars$5.27-2.6%$32.86+523.5%-38.3%$747.87M$74.21M-1.25580News CoverageAnalyst UpgradeDNAGinkgo Bioworks0.7875 of 5 stars$11.38-10.5%$5.77-49.3%N/A$744.53M$227.04M-1.24640News CoverageGap Down Related Companies and Tools Related Companies Avid Bioservices Competitors uniQure Competitors CorMedix Competitors Cronos Group Competitors GH Research Competitors Syndax Pharmaceuticals Competitors Immunome Competitors Gyre Therapeutics Competitors Vir Biotechnology Competitors Ginkgo Bioworks Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DRUG) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bright Minds Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bright Minds Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DRUG Stock Alerts